Dublin, Dec. 07, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/kdzm4v/blood_banking_and) has announced the addition of the "Blood Banking and Blood Products - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
This report analyzes the worldwide markets for Blood Banking and Blood Products in US$ Million by the following Product Group/Types:
- Blood Components and Plasma Products (Whole Blood & Cellular Components; and Plasma Fractions)
- Equipment
- Blood Tests
- Other Consumables
The report profiles 235 companies including many key and niche players such as
- AABB (USA)
- America's Blood Centers (USA)
- American Red Cross (USA)
- Canadian Blood Services (Canada)
- Japan Red Cross Society (Japan)
- New York Blood Center (USA)
- Sanquin Blood Supply Foundation (The Netherlands)
- Leading Players in Blood Bank Technology and Supplies
- Abbott Diagnostics, Inc. (USA)
- Beckman Coulter, Inc. (USA)
- Becton, Dickinson and Company (USA)
- bioMérieux SA (France)
- Bio-Rad Laboratories, Inc. (USA)
- Cerus Corporation (USA)
- CSL Behring LLC (USA)
- Fresenius Kabi AG (Germany)
- Fenwal Inc. (USA)
- Gen-Probe, Inc. (USA)
- Haemonetics Corporation (USA)
- Immucor Inc. (USA)
- Kawasumi Laboratories, Inc. (Japan)
- MacoPharma SA (France)
- Ortho-Clinical Diagnostics, Inc. (USA)
- Terumo BCT Inc. (USA)
- Leading Players in Plasma Fractionation
- Baxter International Inc. (USA)
- Beijing Tiantan Biological Products Co., Ltd (China)
- Bharat Serums and Vaccines Ltd (India)
- Kedrion S.p.A. (Italy)
- LFB Group (France)
- Octapharma AG (Switzerland)
- OMRIX Biopharmaceuticals Ltd (Israel)
- Shanghai RAAS Blood Products Co., Ltd. (China)
- Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China)
Key Topics Covered:
1. Market Overview
2. Market Trends & Issues
3. Competitive Landscape
4. Product Overview
5. Blood Collection Methods
6. The Dynamic Landscape Of Transfusion Technologies & Tests
7. Blood Transfusion: The Process, Tests/Technologies
8. Alternatives To Blood Transfusion: A Real Threat To The Industry
9. Recent Industry Activity
10. Focus On Select Global Players
11. Global Market Perspective
Total Companies Profiled: 235 (including Divisions/Subsidiaries - 273)
- The United States (128)
- Canada (10)
- Japan (12)
- Europe (53)
- - France (4)
- - Germany (16)
- - The United Kingdom (12)
- - Italy (4)
- - Spain (3)
- - Rest of Europe (14)
- Asia-Pacific (Excluding Japan) (63)
- Latin America (3)
- Africa (2)
- Middle East (2)
For more information visit http://www.researchandmarkets.com/research/kdzm4v/blood_banking_and
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Blood Banking


Washington Post Publisher Will Lewis Steps Down After Layoffs
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



